 Phase III, Multicenter, Open Label, Clinical Trial to evaluate safety and efficacy and determine the Maximum Tolerated Dose MTD of Filanesib in combination with pomalidomide and dexamethasone in relapsedrefractory RR Multiple Myeloma MM patients 